Literature DB >> 10428923

Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.

P M Tarantino1, C Zhi, G E Wright, N C Brown.   

Abstract

6-Anilinouracils are selective inhibitors of DNA polymerase III, the enzyme required for the replication of chromosomal DNA in gram-positive bacteria (N. C. Brown, L. W. Dudycz, and G. E. Wright, Drugs Exp. Clin. Res. 12:555-564, 1986). A new class of 6-anilinouracils based on N-3 alkyl substitution of the uracil ring was synthesized and analyzed for activity as inhibitors of the gram-positive bacterial DNA polymerase III and the growth of gram-positive bacterial pathogens. Favorable in vitro properties of N-3-alkyl derivatives prompted the synthesis of derivatives in which the R group at N-3 was replaced with more-hydrophilic methoxyalkyl and hydroxyalkyl groups. These hydroxyalkyl and methoxyalkyl derivatives displayed K(i) values in the range from 0.4 to 2.8 microM against relevant gram-positive bacterial DNA polymerase IIIs and antimicrobial activity with MICs in the range from 0.5 to 15 microg/ml against a broad spectrum of gram-positive bacteria, including methicillin-resistant staphylococci and vancomycin-resistant enterococci. Two of these hydrophilic derivatives displayed protective activity in a simple mouse model of lethal staphylococcal infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428923      PMCID: PMC89401     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  The mechanism of action of inhibitors of DNA synthesis.

Authors:  N R Cozzarelli
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

2.  Inhibition of the synthesis of deoxyribonucleic acid in bacteria by 6-(p-hydroxyphenylazo)-2,4-dihydroxypyrimidine. I. Metabolic studies in Streptococcus fecalis.

Authors:  N C Brown; R E Handschumacher
Journal:  J Biol Chem       Date:  1966-07-10       Impact factor: 5.157

3.  Antibody to B. subtilis DNA polymerase III: use in enzyme purification and examination of homology among replication-specific DNA polymerases.

Authors:  M H Barnes; N C Brown
Journal:  Nucleic Acids Res       Date:  1979-03       Impact factor: 16.971

4.  Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III.

Authors:  G E Wright; J J Gambino
Journal:  J Med Chem       Date:  1984-02       Impact factor: 7.446

5.  The hyperthermophilic bacterium Thermotoga maritima has two different classes of family C DNA polymerases: evolutionary implications.

Authors:  Y P Huang; J Ito
Journal:  Nucleic Acids Res       Date:  1998-12-01       Impact factor: 16.971

6.  Inhibition of Bacillus subtilis DNA polymerase III by arylhydrazinopyrimidines. Novel properties of 2-thiouracil derivatives.

Authors:  G E Wright; N C Brown
Journal:  Biochim Biophys Acta       Date:  1976-04-15

7.  Mapping of the gene specifying DNA polymerase III of Bacillus subtilis.

Authors:  E Love; D D'Ambrosio; N C Brown
Journal:  Mol Gen Genet       Date:  1976-03-30

8.  Inhibition of Bacillus subtilis deoxyribonucleic acid polymerase III by phenylhydrazinopyrimidines. Demonstration of a drug-induced deoxyribonucleic acid-enzyme complex.

Authors:  J E Clements; J D'Ambrosio; N C Brown
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

9.  Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.

Authors:  G E Wright; N C Brown
Journal:  J Med Chem       Date:  1980-01       Impact factor: 7.446

10.  Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracils.

Authors:  N C Brown; J Gambino; G E Wright
Journal:  J Med Chem       Date:  1977-09       Impact factor: 7.446

View more
  13 in total

1.  Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.

Authors:  Chengxin Zhi; Zheng-Yu Long; Andrzej Manikowski; Jeanne Comstock; Wei-Chu Xu; Neal C Brown; Paul M Tarantino; Karsten A Holm; Edward J Dix; George E Wright; Marjorie H Barnes; Michelle M Butler; Kimberly A Foster; William A LaMarr; Benoit Bachand; Richard Bethell; Caroline Cadilhac; Sylvie Charron; Serge Lamothe; Irina Motorina; Richard Storer
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

2.  Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzyme.

Authors:  Alexander Kuhl; Niels Svenstrup; Christoph Ladel; Michael Otteneder; Annegret Binas; Guido Schiffer; Michael Brands; Thomas Lampe; Karl Ziegelbauer; Helga Rübsamen-Waigmann; Dieter Haebich; Kerstin Ehlert
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N(3)-hydroxybutyl 6-(3'-ethyl-4'-methylanilino) uracil.

Authors:  Michelle M Butler; Donna J Skow; Ryan O Stephenson; Patrick T Lyden; William A LaMarr; Kimberly A Foster
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity.

Authors:  Wei-Chu Xu; George E Wright; Neal C Brown; Zheng-Yu Long; Cheng-Xin Zhi; Sofya Dvoskin; Joseph J Gambino; Marjorie H Barnes; Michelle M Butler
Journal:  Bioorg Med Chem Lett       Date:  2011-05-30       Impact factor: 2.823

5.  In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria.

Authors:  J S Daly; T J Giehl; N C Brown; C Zhi; G E Wright; R T Ellison
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

6.  Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.

Authors:  Michelle M Butler; William A Lamarr; Kimberly A Foster; Marjorie H Barnes; Donna J Skow; Patrick T Lyden; Lauren M Kustigian; Chengxin Zhi; Neal C Brown; George E Wright; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

7.  Genome Location Dictates the Transcriptional Response to PolC Inhibition in Clostridium difficile.

Authors:  Erika van Eijk; Ilse M Boekhoud; Ed J Kuijper; Ingrid M J G Bos-Sanders; George Wright; Wiep Klaas Smits
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

8.  DNA polymerases of low-GC gram-positive eubacteria: identification of the replication-specific enzyme encoded by dnaE.

Authors:  Marjorie H Barnes; Shelley D Miller; Neal C Brown
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

9.  Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit.

Authors:  Bing Li; Ramdas Pai; Daniel Aiello; Ming Di; Marjorie H Barnes; Norton P Peet; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem Lett       Date:  2013-04-30       Impact factor: 2.823

10.  Characterization of a novel DNA polymerase activity assay enabling sensitive, quantitative and universal detection of viable microbes.

Authors:  Daniel R Zweitzig; Nichol M Riccardello; Bruce I Sodowich; S Mark O'Hara
Journal:  Nucleic Acids Res       Date:  2012-04-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.